LB Pharmaceuticals Inc Common Stock LBRX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 35.7×-5.8× | 41.4×-6.2× | 47.6×— | —— | 3.6×— | |
| Quick ratio | 35.7×-5.8× | 41.4×-6.2× | 47.6×— | —— | 3.6×— | |
| Cash ratio | 29.4×-4.2× | 33.6×-7.0× | 40.6×— | —— | 2.8×— | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×— | —— | —— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×— | —— | 0.1×— | |
| Per Share | ||||||
| Book value per share | $13.41-64.2% | $37.45-29.9% | $53.42+119% | -$276.88-4.9% | -$263.95-3.6% | |
| Valuation | ||||||
| Market capitalization | $874.06M+163% | $563.16M+58.9% | $354.37M— | —— | —— | |
| Enterprise value | $556.86M— | $316.55M+259% | $88.3M— | —— | —— | |
| Price / book | 2.3×— | 1.9×+0.7× | 1.1×— | —— | —— | |
| Earnings yield | -4.4%— | -4.5%+0.8pp | -5.3%— | —— | —— |
Questions, answered.
- Where do LB Pharmaceuticals Inc Common Stock's ratios come from?
- Every ratio is computed from LB Pharmaceuticals Inc Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.